YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Economic burden attributable to Clostridioides difficile infections in South Korea: a nationwide propensity score-matched study	JOURNAL OF HOSPITAL INFECTION
2022	Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration	CIRCULATION
2022	Reconnection of fragmented parts of coronary arteries using local geometric features in X-ray angiography images	COMPUTERS IN BIOLOGY AND MEDICINE
2022	The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	Impact of Physical Activity on All-Cause Mortality According to Specific Cardiovascular Disease	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	Association of frailty with regional sagittal spinal alignment in the elderly	JOURNAL OF CLINICAL NEUROSCIENCE
2022	Association Between Clinical Burden and Blood Eosinophil Counts in Asthma: Findings From a Korean Adult Asthma Cohort	JOURNAL OF KOREAN MEDICAL SCIENCE
2022	Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2022	Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea	CURRENT PROBLEMS IN CANCER
2022	Ca2+/Calmodulin-Dependent Protein Kinase II Inhibits Hepatitis B Virus Replication from cccDNA via AMPK Activation and AKT/mTOR Suppression	MICROORGANISMS
2022	2021 대한부정맥학회 심방세동 전극도자 및 수술적 절제술 지침	Korean Journal of Medicine
2022	Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
2022	Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis	BMJ OPEN GASTROENTEROLOGY
2022	Development and validation of a prognostic and predictive 32-gene signature for gastric cancer	NATURE COMMUNICATIONS
2022	Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features	CURRENT PROBLEMS IN CANCER
2022	MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer	FUTURE ONCOLOGY
2022	Clinical Outcomes of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon Alone in the Treatment of Femoropopliteal Artery Disease	KOREAN CIRCULATION JOURNAL
2022	SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models	CLINICAL & TRANSLATIONAL IMMUNOLOGY
2022	CRT Efficacy in "Mid-Range" QRS Duration Among Asians Contrasted to Non-Asians, and Influence of Height	JACC. Clinical Electrophysiology
2022	A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial	ANNALS OF ONCOLOGY